期刊文献+

基因工程制药的研究现状与发展前景 被引量:6

The Current Status and Prospects of Research and Development of Genetic Engineering Pharmaceutics
在线阅读 下载PDF
导出
摘要 简要叙述了近年来基因工程技术在医药工业中的应用进展,主要包括基因工程技术在药物生产、新药开发及药物生产工艺改进的应用。随着基因组和蛋白质组研究的深入,基因工程药物将有更多的机会获得突破性进展。 In this paper, the recent application of genetic engineering technology in pharmaceutical industry was introduced briefly. DNA recombinant technology has been playing important roles in medicine production, drugs discovery and development and improvements of pharmaceutical production process. Both genomics and proteomics are contributing to understanding and determining more targets which involved in the development of human disease, which means there would be increasing opportunities for genetic engi- neering pharmaceutical breakthroughs.
作者 汤娇雯
出处 《生物技术通报》 CAS CSCD 北大核心 2009年第8期22-27,31,共7页 Biotechnology Bulletin
关键词 基因工程 重组药物 新药开发 生产工艺改进 Genetic engineering technology Genetic recombinant medicine Drugs discovery and development Improvementof pharmaceutical production process
作者简介 汤娇雯(1979-),女,助理研究员,主要从事科技管理;E-mail:j00228@163.com
  • 相关文献

参考文献16

二级参考文献19

共引文献139

同被引文献66

  • 1潘晟,黄文广.重组质粒PGL3-DF3-DTA对乳腺癌荷瘤裸鼠的治疗研究[J].中国现代医学杂志,2006,16(24):3739-3741. 被引量:1
  • 2马瑞丽.动物细胞工程制药的研究进展[J].科技资讯,2007,5(14):28-29. 被引量:2
  • 3胡显文,陈惠鹏,汤仲明,马清钧.美国、欧盟和中国生物技术药物的比较[J].中国生物工程杂志,2005,25(2):82-94. 被引量:33
  • 4陈少渠,李慧娟.浅谈基因工程疫苗的类型和应用[J].河南畜牧兽医,2005,26(3):9-10. 被引量:6
  • 5Fernando Fratelli, Jose Abrahao-Neto, Aline Tojeira Prestia Caricati. native method for purifying and detoxifying diphtheria toxin [ J ]. Toxin, 2011, (57) :1093-1100.
  • 6Shinji Kakimoto, Toshizumi Tanabe, Hideki Azuma. Enhanced internalization and endosomal escape of dual-functionalized poly (ethyleneimine) s polyplex with diphtheria toxin T and R domains [ J]. Biomedicine & Pharmacotherapy, 2010, (64) :296-301.
  • 7Yi Zhang, Schuhe Wendy, Pink Desmond. Sensitivity of Cancer Cells to Truncated Diphtheria Toxin [ J ]. PLoS ONE, 2010, 5 (5) :1-5.
  • 8Rama Shanker Verma, Sirisha Potala, Mrudula Mathew. Micro- organisms in Sustainable Agriculture and Bioteehnology [ M ]. Springer Netherlands, 2012: 647-662.
  • 9Charles F LeMaistre. Commentary on "DAB389IL-2(ONTAK) : A Novel Fusion Toxin Therapy for Lymphoma" [ J ]. Clinical Lymphoma, 2000, 1 (2) : 117.
  • 10C Frederick LeMaistre. DAB389IL- 2 ( Denileukin Diftitox, ONTAK) : Other Potential Applications [ J]. Clinical Lymphoma, 2000, 1 (1) :37-40.

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部